Trijardy XR 2.5 mg/1 (Empagliflozin, Linagliptin, Metformin Hydrochloride TABLET, EXTENDED RELEASE) 2.5 mg/1

Trijardy XR 2.5 mg/1 is a combination medication containing empagliflozin, linagliptin, and metformin hydrochloride. It is designed to help manage blood sugar levels in adults with type 2 diabetes. This extended-release tablet is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc.

Strength

2.5 mg/1

Pack Size

180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-86)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trijardy XR 2.5 mg/1 is commonly used to help control blood sugar levels in adults with type 2 diabetes. The medication combines three active ingredients: empagliflozin, linagliptin, and metformin hydrochloride, each contributing to the management of glucose levels. This combination therapy is often prescribed when diet and exercise alone are not sufficient to control blood sugar.

Side Effects

Common effects of Trijardy XR 2.5 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, especially when first starting the medication. Some individuals may also experience headaches or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

Trijardy XR 2.5 mg/1 should be handled with care, especially for individuals with certain medical conditions. It is important to inform your healthcare provider if you have a history of kidney problems, as empagliflozin can affect kidney function. Additionally, metformin hydrochloride can cause lactic acidosis in rare cases, so it is crucial to discuss any potential risks with a healthcare professional.

Avoid Interactions

Trijardy XR 2.5 mg/1 may interact with other medications, including certain antibiotics, antifungal agents, and HIV protease inhibitors. These interactions can affect how well the medication works or increase the risk of side effects. It is also important to avoid excessive alcohol consumption while taking this medication, as it can increase the risk of lactic acidosis.

Frequently Asked Questions

Trijardy XR 2.5 mg/1 is used to help manage blood sugar levels in adults with type 2 diabetes.

Trijardy XR 2.5 mg/1 is an extended-release tablet that should be taken orally, typically once daily, with a meal.

Common side effects may include gastrointestinal discomfort, nausea, diarrhea, headaches, and dizziness.

Trijardy XR 2.5 mg/1 may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

Trijardy XR 2.5 mg/1 may not be suitable for individuals with certain medical conditions, such as kidney problems or a history of lactic acidosis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.